Medical Data Science

Data is essential for understanding diseases and their treatment, generating market insights, and making better business decisions. Collecting, analyzing, and implementing medical data is at the core of MedEngine’s Medical Data Science services.

Our team consists of leading scientists with hundreds of scientific publications and years of experience in the field. We execute the projects as a turnkey service from study concept to finalized scientific publication, business report, or algorithm.

We believe that effective implementation of data is a key strategy that makes pharmaceutical and health technology companies thrive in the global market place. That is why we take your projects beyond scientific publication into commercial, medical affairs, and market access activities.

The companies with the best data strategies are the industry leaders of tomorrow

Real World Evidence

It takes very special expertise to tackle real-world data, meaning the data collected outside traditional clinical trials.

Read more

Pharmaceutical and health technology industries are fast-moving domains, in which high-quality therapy area data is essential to stay ahead of the competition.

Read more

MedEngine’s RWInsight is designed to provide profound understanding of the therapy area and target audience.

Read more
Medical Writing

MedEngine’s medical writing services are designed to transform medical data into reports, research documentation, and scientific articles.

Read more

MedEngine – RWE Special


The Current Status and Future Prospects for Real-World Data Research in Finland: A Qualitative Survey 



Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Scand J Gastroenterol. 2021 Aug;56(8):906-913.

Read more

Multiple Myeloma Treatments, Outcomes, and Costs of Health Care Resource Utilisation During 2009-2016, Based on Multiple Data Sources from a Hospital District in Finland. Int J Clin Exp Med Sci 2021; 7(1): 21-30.

Read more

Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer’s Disease Patients: A Finnish Nationwide Cohort Study. J Alzheimers Dis. 2021;81(3):1103-1115.

Read more

See All the Publications